ArticleHeliyon2024

Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.

Phyllis van der Ploeg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.